:
Medical Counter Measures
Prevention, Alert/Response, Mitigation, Recovery, Adaptation/Learning
Biological, Medical Counter Measures
Prevention, Alert/Response, Mitigation, Recovery, Adaptation/Learning
0
0
USA
Civil, military
EU contact is not clear!
EU contact is not clear!
EpiVax employs a “Gene-to-Vaccine design approach for the development of safer, more effective biodefense vaccines against potential bio-warfare agents. Epitopes provide the essential information needed to trigger a protective immune response. Our suite of computational tools (EpiMatrix, Conservatrix, etc.) identifies T cell epitopes of interest that we then validate in vitro and in vivo, for use in final vaccine constructs. We are developing several epitope-based vaccines, including Smallpox, Tularemia, TB, H. Pylori, and Influenza. SPECIFICATIONS CDC biothreat category A Research areas Smallpox, Tularemia, TB, H. Pylori & Influenza Type (C/B/R) [AM] B Type [AM] B
https://cbrneworld.com/directory/products/medical-counter-measures/biodefense-vaccines
+1 401 272
2123